W.R. Berkley Corp’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
AA
LP
TCM
KIM
PAMP
AIMCA
LA
W.R. Berkley Corp's TDAC Position: Q1 2026 in Review
W.R. Berkley Corp increased its Translational Development Acquisition Corp (TDAC) stake by 57% in Q1 2026, buying an estimated $1.05M and bringing the position to 272,950 shares worth $2.89M. The position accounts for 0.16% of the portfolio, ranked #135.
W.R. Berkley Corp first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- W.R. Berkley Corp held 272,950 shares of Translational Development Acquisition Corp worth $2.89M as of Q1 2026.
- W.R. Berkley Corp bought 99,420 Translational Development Acquisition Corp shares in Q1 2026, an estimated $1.05M.
- Translational Development Acquisition Corp made up 0.16% of W.R. Berkley Corp's portfolio in Q1 2026, its #135 holding.
- W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.